ASTH vs CVS
ASTH: Astrana Health operates a technology-driven platform that empowers independent physicians and medical groups to transition to and succeed in value-based care models. CVS: CVS Health is an integrated health care giant combining extensive retail pharmacy networks, pharmacy benefits management, and comprehensive health insurance offerings to simplify consumer health experiences.
Side-by-side fundamentals
| Metric | ASTH | CVS | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $41.94 | $108.08 | |
| Market cap as of 2026-07-23 | $2.1B | $140.4B | |
| P/E as of 2026-07-23 | 70.92 | 47.90 | CVS lower |
| PEG as of 2026-07-23 | n/a | 3.33 | |
| Net margin as of 2026-07-23 | +0.9% | +0.7% | ASTH higher |
| Gross margin as of 2026-07-23 | +10.7% | +13.9% | CVS higher |
| Operating margin as of 2026-07-23 | +2.5% | +1.6% | ASTH higher |
| ROE as of 2026-07-23 | +3.9% | +3.9% | ASTH higher |
| ROA as of 2026-07-23 | +1.5% | +1.1% | ASTH higher |
| Debt / equity as of 2026-07-23 | 1.28 | 0.81 | CVS lower |
| Revenue growth (YoY) as of 2026-07-23 | +56.7% | +7.6% | ASTH higher |
| Revenue CAGR (3y) SEC XBRL | +40.6% | +7.6% | ASTH higher |
| Dividend yield as of 2026-07-23 | +0.1% | +2.4% | CVS higher |
| Dividend streak (yrs) SEC XBRL | n/a | 5 | |
| Beta as of 2026-07-23 | 0.87 | 0.59 | |
| 1-year return as of 2026-07-22 close | +97.3% | +76.9% | ASTH higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.